Education
About Us
Working with TipRanks
Follow Us
Omeros Corporation (OMER)
:OMER
Earnings Data
Report Date
Mar 03, 2026After Close (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.52Last Year’s EPS
-0.54Same Quarter Last Year
Moderate Buy
Based on 3 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
Omeros Corporation's earnings call highlighted a strategic partnership with Novo Nordisk, significant progress in regulatory approvals for Yartemlia, and improved financial positioning through debt repayment. Despite reporting a higher net loss and cash burn, the company's robust pipeline and upcoming milestones position it for potential future success.Company Guidance
Strategic Partnership with Novo Nordisk
Omeros Corporation announced a definitive agreement with Novo Nordisk for an asset purchase and license transaction valued at up to $2.1 billion, including $240 million in upfront cash and additional milestone payments.
Yartemlia (Narsoplimab) Regulatory Progress
The biologics license application for Yartemlia in the treatment of TATMA is under FDA review with a PDUFA date of December 26, 2025. The EMA is also reviewing Yartemlia, with a decision expected in mid-2026.
Financial Position and Debt Management
Omeros Corporation plans to use the $240 million upfront payment from Novo Nordisk to fully repay its $67.1 million term loan and remaining 2026 convertible notes, significantly improving its financial position.
Strong Pipeline and Future Prospects
Omeros Corporation continues to advance its MASP-2, PDE-7, TCAT, and oncology programs, with Yartemlia expected to transform transplant patient outcomes and strategic capital to fuel further growth.
OMER Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
OMER Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 13, 2025 | $6.28 | $7.87 | +25.32% |
Aug 14, 2025 | $4.12 | $4.41 | +7.04% |
May 15, 2025 | $3.95 | $3.22 | -18.48% |
Mar 31, 2025 | $8.22 | $7.91 | -3.77% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Omeros Corporation (OMER) report earnings?
Omeros Corporation (OMER) is schdueled to report earning on Mar 03, 2026, After Close (Confirmed).
What is Omeros Corporation (OMER) earnings time?
Omeros Corporation (OMER) earnings time is at Mar 03, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is OMER EPS forecast?
OMER EPS forecast for the fiscal quarter 2025 (Q4) is -0.52.